Skip to main content
SpringerLink
Log in

Hepatitis Viruses, Atherosclerosis, and Related Diseases

  • Chapter
  • First Online:
Viruses and Atherosclerosis

Part of the book series: SpringerBriefs in Immunology ((BRIEFSIMMUN,volume 4))

Abstract

In this chapter, a role of various hepatitis viruses in the development of atherosclerosis will be discussed. At the moment, it is hard to conclude definitely whether HAV is associated with atherosclerosis and related diseases but it seems to be that this correlation is population-dependent, and may be based on the causation of endothelial dysfunction. Regarding HBV, the reliable association of the chronic infection caused by this virus with atherosclerosis and related diseases was not revealed. Finally, it was demonstrated that chronic HCV infection is associated with subclinical atherosclerosis, CAD, and stroke, most probably through the direct inflammatory mechanism.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Zhu J, Quyyumi AA, Norman JE, Costello R, Csako G, Epstein SE. The possible role of hepatitis A virus in the pathogenesis of atherosclerosis. J Infect Dis. 2000;182:1583–7.

    Article  PubMed  CAS  Google Scholar 

  2. Zhu J, Nieto FJ, Horne BD, Anderson JL, Muhlestein JB, Epstein SE. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation. 2001;103:45–51.

    Article  PubMed  CAS  Google Scholar 

  3. Prasad A, Zhu J, Halcox JP, Waclawiw MA, Epstein SE, Quyyumi AA. Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation. 2002;106:184–90.

    Article  PubMed  Google Scholar 

  4. Cainelli F, Concia E, Vento S. Hepatitis A virus infection and atherosclerosis. J Infect Dis. 2001;184:390–1.

    Article  PubMed  CAS  Google Scholar 

  5. Ramia S. Antibody against hepatitis A in Saudi Arabians and in expatriates from various parts of the world working in Saudi Arabia. J Infect. 1986;12:153–5.

    Article  PubMed  CAS  Google Scholar 

  6. Darwish MA, Faris R, Clemens JD, Rao MR, Edelman R. High seroprevalence of hepatitis A, B, C, and E viruses in residents in an Egyptian village in the Nile delta: a pilot study. Am J Trop Med Hyg. 1996;54:554–8.

    PubMed  CAS  Google Scholar 

  7. Mele A, Pasquini P, Pana A. Hepatitis A in Italy: epidemiology and suggestions for control. Ital J Gastroenterol. 1991;23:341–3.

    PubMed  CAS  Google Scholar 

  8. Amin J, Heath T, Morrell S. Hepatitis A in Australia in the 1990s: future directions in surveillance and control. Commun Dis Intell. 1999;23:113–20.

    PubMed  CAS  Google Scholar 

  9. Massaro M, Carluccio MA, De Caterina R. Direct vascular antiatherogenic effects of oleic acid: a clue to the cardioprotective effects of the Mediterranean diet. Cardiologia. 1999;44: 507–13.

    PubMed  CAS  Google Scholar 

  10. Pearson TA. Cardiovascular disease in developing countries: myths, realities, and opportunities. Cardiovasc Drugs Ther. 1999;13:95–104.

    Article  PubMed  CAS  Google Scholar 

  11. Smieja M, Cronin L, Levine M, Goldsmith CH, Yusuf S, Mahony JB. Previous exposure to Chlamydia pneumoniae, Helicobacter pylori and other infections in Canadian patients with ischemic heart disease. Can J Cardiol. 2001;17:270–6.

    PubMed  CAS  Google Scholar 

  12. Burnett MS, Zhu J, Miller JM, Epstein SE. Effects of hepatitis A vaccination on atherogenesis in a murine model. J Viral Hepat. 2003;10:433–6.

    Article  PubMed  CAS  Google Scholar 

  13. Auer J, Leitinger M, Berent R, Prammer W, Weber T, Lassnig E, Eber B. Hepatitis A IgG seropositivity and coronary atherosclerosis assessed by angiography. Int J Cardiol. 2003;90: 175–9.

    Article  PubMed  CAS  Google Scholar 

  14. Ongey M, Brenner H, Thefeld W, Rothenbacher D. Helicobacter pylori and hepatitis A virus infections and the cardiovascular risk profile in patients with diabetes mellitus: results of a population-based study. Eur J Cardiovasc Prev Rehabil. 2004;11:471–6.

    Article  PubMed  Google Scholar 

  15. Smieja M, Gnarpe J, Lonn E, Gnarpe H, Olsson G, Yi Q, Dzavik V, McQueen M, Yusuf S, Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Multiple infections and subsequent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation. 2003;107:251–7.

    Article  PubMed  Google Scholar 

  16. Ishizaka N, Ishizaka Y, Takahashi E, Toda Ei E, Hashimoto H, Ohno M, Nagai R, Yamakado M. Increased prevalence of carotid atherosclerosis in hepatitis B virus carriers. Circulation. 2002;105:1028–30.

    Article  PubMed  Google Scholar 

  17. Bilora F, Rinaldi R, Boccioletti V, Petrobelli F, Girolami A. Chronic viral hepatitis: a prospective factor against atherosclerosis. A study with echo-color Doppler of the carotid and femoral arteries and the abdominal aorta. Gastroenterol Clin Biol. 2002;26:1001–4.

    PubMed  CAS  Google Scholar 

  18. Völzke H, Schwahn C, Wolff B, Mentel R, Robinson DM, Kleine V, Felix SB, John U. Hepatitis B and C virus infection and the risk of atherosclerosis in a general population. Atherosclerosis. 2004;174:99–103.

    Article  PubMed  Google Scholar 

  19. Su TC, Lee YT, Cheng TJ, Chien HP, Wang JD. Chronic hepatitis B virus infection and dyslipidemia. J Formos Med Assoc. 2004;103:286–91.

    PubMed  Google Scholar 

  20. Tong DY, Wang XH, Xu CF, Yang YZ, Xiong SD. Hepatitis B virus infection and coronary atherosclerosis: results from a population with relatively high prevalence of hepatitis B virus. World J Gastroenterol. 2005;11:1292–6.

    PubMed  Google Scholar 

  21. Ghotaslou R, Aslanabadi N, Ghojazadeh M. Hepatitis B virus infection and the risk of coronary atherosclerosis. Ann Acad Med Singapore. 2008;37:913–5.

    PubMed  Google Scholar 

  22. Yang KC, Chen MF, Su TC, Jeng JS, Hwang BS, Lin LY, Liau CS, Lee YT. Hepatitis B virus seropositivity is not associated with increased risk of carotid atherosclerosis in Taiwanese. Atherosclerosis. 2007;195:392–7.

    Article  PubMed  CAS  Google Scholar 

  23. Sung J, Song YM, Choi YH, Ebrahim S, Davey Smith G. Hepatitis B virus seropositivity and the risk of stroke and myocardial infarction. Stroke. 2007;38:1436–41.

    Article  PubMed  Google Scholar 

  24. Turhan O, Coban E, Inan D, Yalcin AN. Increased mean platelet volume in chronic hepatitis B patients with inactive disease. Med Sci Monit. 2010;16:CR202–5.

    PubMed  CAS  Google Scholar 

  25. Wang CH, Chen CJ, Lee MH, Yang HI, Hsiao CK. Chronic hepatitis B infection and risk of atherosclerosis-related mortality: a 17-year follow-up study based on 22,472 residents in Taiwan. Atherosclerosis. 2010;211:624–9.

    Article  PubMed  CAS  Google Scholar 

  26. Grub C, Brunborg C, Hasseltvedt V, Aukrust P, Førre O, Almdahl SM, Hollan I. Antibodies to common infectious agents in coronary artery disease patients with and without rheumatic conditions. Rheumatology (Oxford). 2012;51:679–85.

    Article  CAS  Google Scholar 

  27. Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group, Weber R, Sabin C, Reiss P, de Wit S, Worm SW, Law M, Dabis F, D’Arminio Monforte A, Fontas E, El-Sadr W, Kirk O, Rickenbach M, Phillips A, Ledergerber B, Lundgren J. HBV or HCV coinfections and risk of myocardial infarction in HIV-infected individuals: the D:A:D Cohort Study. Antivir Ther. 2010;15:1077–86.

    Article  PubMed  Google Scholar 

  28. Marzouk D, Sass J, Bakr I, El Hosseiny M, Abdel-Hamid M, Rekacewicz C, Chaturvedi N, Mohamed MK, Fontanet A. Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt. Gut. 2007;56:1105–10.

    Article  PubMed  CAS  Google Scholar 

  29. Boddi M, Abbate R, Chellini B, Giusti B, Giannini C, Pratesi G, Rossi L, Pratesi C, Gensini GF, Paperetti L, Zignego AL. Hepatitis C virus RNA localization in human carotid plaques. J Clin Virol. 2010;47:72–5.

    Article  PubMed  CAS  Google Scholar 

  30. Masiá M, Robledano C, López N, Escolano C, Gutiérrez F. Treatment for hepatitis C virus with pegylated interferon-α plus ribavirin induces anti-atherogenic effects oncardiovascular risk biomarkers in HIV-infected and -uninfected patients. J Antimicrob Chemother. 2011;66: 1861–8.

    Article  PubMed  Google Scholar 

  31. Masiá M, Padilla S, Robledano C, Ramos JM, Gutiérrez F. Evaluation of endothelial function and subclinical atherosclerosis in association with hepatitis C virus in HIV-infected patients: a cross-sectional study. BMC Infect Dis. 2011;11:265.

    Article  PubMed  Google Scholar 

  32. Oliveira CP, Kappel CR, Siqueira ER, Lima VM, Stefano JT, Michalczuk MT, Marini SS, Barbeiro HV, Soriano FG, Carrilho FJ, Pereira LM, Alvares-da-Silva MR. Effects of Hepatitis C virus on cardiovascular risk in infected patients: a comparative study. Int J Cardiol. 2013;164(2):221–6.

    Article  PubMed  CAS  Google Scholar 

  33. Perrin-Cocon L, Diaz O, André P, Lotteau V. Modified lipoproteins provide lipids that modulate dendritic cell immune function. Biochimie. 2013;95(1):103–8.

    Article  PubMed  CAS  Google Scholar 

  34. Ishizaka Y, Ishizaka N, Takahashi E, Unuma T, Tooda E, Hashimoto H, Nagai R, Yamakado M. Association between hepatitis C virus core protein and carotid atherosclerosis. Circ J. 2003;67:26–30.

    Article  PubMed  CAS  Google Scholar 

  35. Targher G, Bertolini L, Padovani R, Rodella S, Arcaro G, Day C. Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C. J Hepatol. 2007;46:1126–32.

    Article  PubMed  CAS  Google Scholar 

  36. Sawayama Y, Okada K, Maeda S, Ohnishi H, Furusyo N, Hayashi J. Both hepatitis C virus and Chlamydia pneumoniae infection are related to the progression of carotid atherosclerosis in patients undergoing lipid lowering therapy. Fukuoka Igaku Zasshi. 2006;97:245–55.

    PubMed  Google Scholar 

  37. Caliskan Y, Oflaz H, Pusuroglu H, Boz H, Yazici H, Tamer S, Karsidag K, Yildiz A. Hepatitis C virus infection in hemodialysis patients is not associated with insulin resistance, inflammation and atherosclerosis. Clin Nephrol. 2009;71:147–57.

    Article  PubMed  CAS  Google Scholar 

  38. Tien PC, Schneider MF, Cole SR, Cohen MH, Glesby MJ, Lazar J, Young M, Mack W, Hodis HN, Kaplan RC. Association of hepatitis C virus and HIV infection with subclinical atherosclerosis in the women’s interagency HIV study. AIDS. 2009;23:1781–4.

    Article  PubMed  Google Scholar 

  39. Miyajima I, Kawaguchi T, Fukami A, Nagao Y, Adachi H, Sasaki S, Imaizumi T, Sata M. Chronic HCV infection was associated with severe insulin resistance and mild atherosclerosis: a population-based study in an HCV hyperendemic area. J Gastroenterol. 2013;48(1):93–100.

    Article  PubMed  Google Scholar 

  40. Sosner P, Wangermez M, Chagneau-Derrode C, Le Moal G, Silvain C. Atherosclerosis risk in HIV-infected patients: the influence of hepatitis C virus co-infection. Atherosclerosis. 2012; 222:274–7.

    Article  PubMed  CAS  Google Scholar 

  41. Vassalle C, Masini S, Bianchi F, Zucchelli GC. Evidence for association between hepatitis C virus seropositivity and coronary artery disease. Heart. 2004;90:565–6.

    Article  PubMed  CAS  Google Scholar 

  42. Tsui JI, Whooley MA, Monto A, Seal K, Tien PC, Shlipak M. Association of hepatitis C virus seropositivity with inflammatory markers and heart failure in persons with coronary heart disease: data from the Heart and Soul study. J Card Fail. 2009;15:451–6.

    Article  PubMed  CAS  Google Scholar 

  43. Butt AA, Xiaoqiang W, Budoff M, Leaf D, Kuller LH, Justice AC. Hepatitis C virus infection and the risk of coronary disease. Clin Infect Dis. 2009;49:225–32.

    Article  PubMed  Google Scholar 

  44. Arcari CM, Nelson KE, Netski DM, Nieto FJ, Gaydos CA. No association between hepatitis C virus seropositivity and acute myocardial infarction. Clin Infect Dis. 2006;43:e53–6.

    Article  PubMed  Google Scholar 

  45. Bedimo R, Westfall AO, Mugavero M, Drechsler H, Khanna N, Saag M. Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patients. HIV Med. 2010;11:462–8.

    PubMed  CAS  Google Scholar 

  46. Liao CC, Su TC, Sung FC, Chou WH, Chen TL. Does hepatitis C virus infection increase risk for stroke? A population-based cohort study. PLoS One. 2012;7:e31527.

    Article  PubMed  CAS  Google Scholar 

  47. Lee MH, Yang HI, Wang CH, Jen CL, Yeh SH, Liu CJ, You SL, Chen WJ, Chen CJ. Hepatitis C virus infection and increased risk of cerebrovascular disease. Stroke. 2010;41:2894–900.

    Article  PubMed  Google Scholar 

  48. Ishizaka N, Ishizaka Y, Takahashi E, Tooda E, Hashimoto H, Nagai R, Yamakado M. Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening. Lancet. 2002;359:133–5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Epidemiology, Kemerovo State Medical Academy, Kemerovo, Russia

    Anton Kutikhin & Elena Brusina

  2. Res Inst Cardiovascular Diseases, Russian Academy of Medical Sciences Siberian Branch, Kemerovo, Russia

    Arseniy E. Yuzhalin

  3. Department of Oncology, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, UK, OX3 7DQ

    Arseniy E. Yuzhalin

Authors
  1. Anton Kutikhin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elena Brusina
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Arseniy E. Yuzhalin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Kutikhin, A., Brusina, E., Yuzhalin, A.E. (2013). Hepatitis Viruses, Atherosclerosis, and Related Diseases. In: Viruses and Atherosclerosis. SpringerBriefs in Immunology, vol 4. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8863-7_5

Download citation

Publish with us

Policies and ethics

Search

Navigation